Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Study Objectives This study aims to investigate the effects of preoperative stellate ganglion block and intraoperative intravenous dexmedetomidine on postoperative sleep disturbance in patients undergoing laparoscopic gynecologic surgery, with the goals of reducing pain and postoperative adverse reactions and identifying an effective, safe, economical, and broadly applicable intervention strategy that may facilitate emergence from anesthesia, accelerate postoperative recovery, shorten the length of hospital stay, and reduce hospitalization costs. This trial aims to determine whether preoperative stellate ganglion block (SGB) and intraoperative intravenous dexmedetomidine (DEX) can improve postoperative sleep quality in patients undergoing laparoscopic gynecologic surgery, and whether the combination of these two interventions provides an interaction effect or additional ben
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-75 lat
- •Ogólny stan zdrowia pozwalający na operację (ASA 1-3)
- •Planowana laparoskopowa operacja ginekologiczna (usunięcie macicy lub usunięcie mięśniaków macicy)
✗ Disqualifies
- •Ból gardła lub chrypka przed operacją
- •Infekcja górnych dróg oddechowych w ciągu ostatnich 2 tygodni
- •Przewidywane trudności z intubacją (spekularna deformacja twarzy, mały otwar ust)
- •Poważne problemy z sercem, wątrobą, nerkami lub innymi organami
- •Alergia na leki znieczulające, infekcja w miejscu zabiegu lub zaburzenia krzepnięcia krwi
- •Zaburzenia poznawcze, głuchota, trudności z porozumieniem się lub zaburzenia psychiczne
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- October 6, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Huai'an Second People's Hospital
Huai'an, China
Trial contact
Jun Wang
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.